Karina Makarenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Karina Makarenko has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Enrico Ferrazzi
Unit of Obstetrics, Department of Woman, Child and Neonate Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
1 shared publication Gian Benedetto Melis
Department of Obstetrics and Gynecology and Human Reproduction Physiopathology, University of Cagliari, 09124 Cagliari, Italy
1 shared publication- Luigi Atzori
Clinical Metabolomics Unit, Department of Biomedical Sciences, University of Cagliari, 09042 Cagliari, Italy
1 shared publication Vassilios Fanos
NICU, Puericulture Institute and Neonatal Section, AOU and University of Cagliari, 09124 Cagliari, Italy
1 shared publication
Latest Publications
- Open Access
- 9 June 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Metabolomics Application in Maternal-Fetal Medicine
Metabolomics in maternal-fetal medicine is still an “embryonic” science. However, there is already an increasing interest in metabolome of normal and complicated pregnancies, and neonatal outcomes. Tissues used for metabolomics interrogations of pregnant women, fetuses and newborns are amniotic fluid, blood, plasma, cord blood, placenta, urine, and vaginal secretions. All published papers highlight the strong correlation between biomarkers found in these tissues and fetal malformations, preterm delivery, premature rupture of membranes, gestational diabetes mellitus, preeclampsia, neonatal asphyxia, and hypoxic-ischemic encephalopathy. The aim of this review is to summarize and comment on original data available in relevant published works in order to emphasize the clinical potential of metabolomics in obstetrics in the immediate future.
- 9 June 2013
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-9
Open AccessMetabolomics Application in Maternal-Fetal Medicine
Metabolomics in maternal-fetal medicine is still an “embryonic” science. However, there is already an increasing interest in metabolome of normal and complicated pregnancies, and neonatal outcomes. Tissues used for metabolomics interrogations of pregnant women, fetuses and newborns are amniotic fluid, blood, plasma, cord blood, placenta, urine, and vaginal secretions. All published papers highlight the strong correlation between biomarkers found in these tissues and fetal malformations, preterm delivery, premature rupture of membranes, gestational diabetes mellitus, preeclampsia, neonatal asphyxia, and hypoxic-ischemic encephalopathy. The aim of this review is to summarize and comment on original data available in relevant published works in order to emphasize the clinical potential of metabolomics in obstetrics in the immediate future.